Cargando…

Nanostructured Lipid Carriers Deliver Resveratrol, Restoring Attenuated Dilation in Small Coronary Arteries, via the AMPK Pathway

Nanostructured lipid carriers (NLCs) are an emerging drug delivery platform for improved drug stability and the bioavailability of antihypertensive drugs and vasoprotective nutraceutical compounds, such as resveratrol (RV). The objective of this study was to ascertain NLCs’ potential to deliver RV a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Astley, Cai, Houacine, Chahinez, Zaabalawi, Azziza, Wilkinson, Fiona, Lightfoot, Adam P., Alexander, Yvonne, Whitehead, Debra, Singh, Kamalinder K., Azzawi, May
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8699041/ https://www.ncbi.nlm.nih.gov/pubmed/34944670 http://dx.doi.org/10.3390/biomedicines9121852

Ejemplares similares

Tetramethoxystilbene-Loaded Liposomes Restore Reactive-Oxygen-Species-Mediated Attenuation of Dilator Responses in Rat Aortic Vessels Ex vivo
por: Zaabalawi, Azziza, et al.
Publicado: (2019)

Internal Mammary Arteries as a Model to Demonstrate Restoration of the Impaired Vasodilation in Hypertension, Using Liposomal Delivery of the CYP1B1 Inhibitor, 2,3′,4,5′-Tetramethoxystilbene
por: Zaabalawi, Azziza, et al.
Publicado: (2022)

Polyvinylpyrrolidone-coated gold nanoparticles inhibit endothelial cell viability, proliferation, and ERK1/2 phosphorylation and reduce the magnitude of endothelial-independent dilator responses in isolated aortic vessels
por: Mohamed, Teba, et al.
Publicado: (2017)

Nanostructured lipid carriers loaded with resveratrol modulate human dendritic cells
por: Barbosa, João P, et al.
Publicado: (2016)

Augmented Oral Bioavailability and Prokinetic Activity of Levosulpiride Delivered in Nanostructured Lipid Carriers
por: Arif, Sadia Tabassam, et al.
Publicado: (2022)

Inhalation treatment of cystic fibrosis with lumacaftor and ivacaftor co-delivered by nanostructured lipid carriers
por: Garbuzenko, O.B., et al.
Publicado: (2019)

Resveratrol-loaded solid lipid nanoparticles versus nanostructured lipid carriers: evaluation of antioxidant potential for dermal applications
por: Gokce, Evren H, et al.
Publicado: (2012)

A Facile and Novel Approach to Manufacture Paclitaxel-Loaded Proliposome Tablet Formulations of Micro or Nano Vesicles for Nebulization
por: Khan, Iftikhar, et al.
Publicado: (2020)

Nanostructured lipid carriers co-delivering lapachone and doxorubicin for overcoming multidrug resistance in breast cancer therapy
por: Li, Xin, et al.
Publicado: (2018)

Nanostructured Lipid Carriers Delivering Sorafenib to Enhance Immunotherapy Induced by Doxorubicin for Effective Esophagus Cancer Therapy
por: Wang, Jia-Yang, et al.
Publicado: (2020)

Modeling of the surface plasmon resonance tunability of silver/gold core–shell nanostructures
por: Chahinez, Dab, et al.
Publicado: (2018)

Nanostructured lipid carrier delivering chlorins e6 as in situ dendritic cell vaccine for immunotherapy of gastric cancer
por: Mao, Mao, et al.
Publicado: (2020)

Retraction of “Nanostructured Lipid Carriers Delivering Sorafenib to Enhance Immunotherapy Induced by Doxorubicin for Effective Esophagus Cancer Therapy”
por: Wang, Jia-Yang, et al.
Publicado: (2021)

Resveratrol relieves gestational diabetes mellitus in mice through activating AMPK
por: Yao, Liangqi, et al.
Publicado: (2015)

Antineoplastics Encapsulated in Nanostructured Lipid Carriers
por: Rodrigues da Silva, Gustavo Henrique, et al.
Publicado: (2021)

Nanostructured Lipid Carriers: A potential drug carrier for cancer chemotherapy
por: Selvamuthukumar, Subramanian, et al.
Publicado: (2012)

SIRT1 Takes a Backseat to AMPK in the Regulation of Insulin Sensitivity by Resveratrol
por: Fullerton, Morgan D., et al.
Publicado: (2010)

Resveratrol-Activated AMPK/SIRT1/Autophagy in Cellular Models of Parkinson's Disease
por: Wu, Yuncheng, et al.
Publicado: (2011)

Resveratrol suppresses glial activation and alleviates trigeminal neuralgia via activation of AMPK
por: Yang, Yan-jing, et al.
Publicado: (2016)

Nanostructures as Radionuclide Carriers in Auger Electron Therapy
por: Gharibkandi, Nasrin Abbasi, et al.
Publicado: (2022)

Using Liposomes as Carriers for Polyphenolic Compounds: The Case of Trans-Resveratrol
por: Bonechi, Claudia, et al.
Publicado: (2012)

Recent progress in nanotechnology-based drug carriers for resveratrol delivery
por: Li, Chunhong, et al.
Publicado: (2023)

Nanostructured Chitosan-Based Biomaterials for Sustained and Colon-Specific Resveratrol Release
por: Iglesias, Nieves, et al.
Publicado: (2019)

Nanostructured Lipid Carriers Loaded with Baicalin: An Efficient Carrier for Enhanced Antidiabetic Effects
por: Shi, Feng, et al.
Publicado: (2016)

Involvement of 5′AMP-Activated Protein Kinase (AMPK) in the Effects of Resveratrol on Liver Steatosis
por: Trepiana, Jenifer, et al.
Publicado: (2018)

Impact of Coronavirus Disease 2019 on Geriatric Psychiatry
por: Bankole, Azziza
Publicado: (2022)

Optical near-field mapping of plasmonic nanostructures prepared by nanosphere lithography
por: Kolhatkar, Gitanjali, et al.
Publicado: (2018)

Amelioration of High-Insulin-Induced Skeletal Muscle Cell Insulin Resistance by Resveratrol Is Linked to Activation of AMPK and Restoration of GLUT4 Translocation
por: Vlavcheski, Filip, et al.
Publicado: (2020)

Resveratrol Encapsulation and Release from Pristine and Functionalized Mesoporous Silica Carriers
por: Ioniţă, Simona, et al.
Publicado: (2022)

Improvement of fluvastatin bioavailability by loading on nanostructured lipid carriers
por: El-Helw, Abdel-Rahim M, et al.
Publicado: (2015)

Nanostructured lipid carriers: versatile oral delivery vehicle
por: Poonia, Neelam, et al.
Publicado: (2016)

Characterization and toxicity of citral incorporated with nanostructured lipid carrier
por: Nordin, Noraini, et al.
Publicado: (2018)

Nanostructured carriers as innovative tools for cancer diagnosis and therapy
por: Martinelli, Chiara, et al.
Publicado: (2019)

Oral Bioavailability Enhancement of Raloxifene with Nanostructured Lipid Carriers
por: Murthy, Aditya, et al.
Publicado: (2020)

Biodistribution of Nanostructured Lipid Carriers in Mice Atherosclerotic Model
por: Devel, Laurent, et al.
Publicado: (2019)

Nanostructured Lipid Carriers for Delivery of Chemotherapeutics: A Review
por: Haider, Mohamed, et al.
Publicado: (2020)

Unraveling the pulmonary drug delivery carriers in inhalable nanostructures
por: Huang, Zhengwei, et al.
Publicado: (2022)

Solution-Processed Metal Oxide Nanostructures for Carrier Transport
por: Yang, Sheng-Hsiung
Publicado: (2023)

Generation of High Dose Inhalable Effervescent Dispersions against Pseudomonas aeruginosa Biofilms
por: Mohammed, Aram, et al.
Publicado: (2020)

Resveratrol Induces Vascular Smooth Muscle Cell Differentiation through Stimulation of SirT1 and AMPK
por: Thompson, Anne Marie, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_mksilks16afc9j344t24e9mggi